ANI Pharmaceuticals Inc (ANIP)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 1.294 | -0.293 | 3.677 | 1.373 | -4.913 | -6.942 | -6.466 | 2.061 |
Return on Equity (%) | 2.386 | -0.625 | 8.33 | 2.972 | -11.04 | -16.161 | -15.294 | 4.596 |
Return on Invested Capital (%) | 16.854 | 12.762 | 21.758 | 20.749 | 8.476 | 4.05 | 5.283 | 16.997 |
Operating Margin (%) | 15.553 | 16.05 | 17.268 | 7.806 | -7.919 | -20.42 | -10.94 | 9.616 |
Net Profit Margin (%) | 3.059 | -0.608 | 7.686 | 2.95 | -10.816 | -19.799 | -15.652 | 3.524 |
Book Value Per Share | -0.688 | -4.877 | -0.668 | 2.382 | 0.29 | 2.181 | 3.352 | 10.782 |
Earnings Per Share | 0.339 | -0.092 | 1.306 | 0.504 | -1.812 | -2.541 | -2.829 | 0.839 |
Cash Per Share | 2.359 | 2.671 | 3.626 | 5.151 | 0.632 | 5.956 | 2.755 | 10.819 |
Working Capital Per Share | 6.126 | 7.922 | -1.068 | 10.414 | 7.375 | 13.909 | 13.986 | 18.316 |
Operating Profit Per Share | 6.884 | 8.388 | 10.837 | 11.85 | 9.751 | 6.86 | 10.146 | 14.938 |
EBIT Per Share | 0.748 | 1.402 | 1.69 | 0.261 | -2.087 | -3.329 | -3.58 | 0.972 |
EBITDA Per Share | 0.748 | 1.402 | 1.69 | 0.261 | -2.087 | -3.329 | -3.58 | 0.972 |
Free Cash Flow Per Share | 11.264 | 6.774 | -0.618 | -0.906 | 0.091 | -3.943 | -5.144 | -1.18 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 11,59M | 11,65M | 11,85M | 12,09M | 12,43M | 16,83M | 17,49M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 17,49M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | 9.234 | N/A | N/A | N/A | 21.782 | N/A | N/A |
Net Profit Margin (%) | N/A | 0.967 | N/A | N/A | N/A | 12.953 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 1,14B |
Ratio cours/bénéfice | 66,37 |
Ratio prix/ventes | 2,34 |
Ratio prix/liquidités | 5,15 |
Ratio prix/valeur comptable | 2,49 |
Rendement de dividende | - |
Actions en circulation | 21,03M |
Volume moyen (1 semaine) | 176,09k |
Volume moyen (1 mois) | 298,47k |
Variation sur 52 semaines | -2,41% |
Plus haut sur 52 semaines | 70,81 |
Plus bas sur 52 semaines | 52,50 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales